Researchers find new strategies to help immunotherapy annihilate cancerCombining checkpoint inhibitors with targeted drugs like JAK inhibitors enhances immune system response in resistant cancer cases.
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours - NatureGDF-15 targeting may improve cancer treatment efficacy alongside existing anti-PD-1 therapies.Clinical trials indicate the potential of visugromab in overcoming immune escape mechanisms in tumours.
Researchers find new strategies to help immunotherapy annihilate cancerCombining checkpoint inhibitors with targeted drugs like JAK inhibitors enhances immune system response in resistant cancer cases.
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours - NatureGDF-15 targeting may improve cancer treatment efficacy alongside existing anti-PD-1 therapies.Clinical trials indicate the potential of visugromab in overcoming immune escape mechanisms in tumours.